$CDLX
Cardlytics, Inc. Stock $cdlx

$cdlx Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000166607122000022 Filed on March 01, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$90.05M	$267.1M	$67.08M
YoY Change	34.24%	42.93%	-3.19%
Cost Of Revenue	$46.46M	$137.4M	$38.39M
YoY Change	21.02%	30.36%	-1.54%
Gross Profit	$43.59M	$129.7M	$28.69M
YoY Change	51.93%	59.16%	-5.34%
Gross Profit Margin	48.41%	48.56%	42.77%
Selling, General & Admin	$42.01M	$132.2M	$27.71M
YoY Change	51.61%	43.97%	12.0%
% of Gross Profit	96.38%	101.93%	96.58%
Research & Development	$11.51M	$38.10M	$5.090M
YoY Change	126.15%	117.34%	71.96%
% of Gross Profit	26.41%	29.38%	17.74%
Depreciation & Amortization	$9.598M	$29.87M	$2.020M
YoY Change	375.15%	281.69%	48.53%
% of Gross Profit	22.02%	23.03%	7.04%
Operating Expenses	$56.75M	$170.3M	$34.81M
YoY Change	63.04%	55.73%	19.83%
Operating Profit	-$13.16M	-$122.6M	-$6.120M
YoY Change	115.08%	127.36%	-585.71%
Interest Expense	-$3.290M	-$13.83M	-$660.0K
YoY Change	398.48%	822.0%	-312.9%
% of Operating Profit
Other Income/Expense, Net		-$13.83M
YoY Change		822.62%
Pretax Income	-$19.70M	-$136.4M	-$6.780M
YoY Change	190.55%	146.16%	-297.67%
Income Tax	-$7.864M	$7.864M	$0.00
% Of Pretax Income
Net Earnings	-$11.84M	-$128.6M	-$6.780M
YoY Change	74.56%	131.97%	-297.67%
Net Earnings / Revenue	-13.14%	-48.13%	-10.11%
Basic Earnings Per Share		-$3.99
Diluted Earnings Per Share	-$354.3K	-$3.992M	-$244.7K
COMMON SHARES
Basic Shares Outstanding	33.27M shares	32.20M shares	27.46M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$233.5M	$233.5M	$293.2M
YoY Change	-20.37%	-20.37%	180.57%
Cash & Equivalents	$233.5M	$233.5M	$293.2M
Short-Term Investments
Other Short-Term Assets	$8.076M	$8.076M	$5.800M
YoY Change	39.24%	39.24%	-1.69%
Inventory
Prepaid Expenses
Receivables	$111.1M	$111.1M	$81.25M
Other Receivables	$6.097M	$6.097M	$5.306M
Total Short-Term Assets	$358.7M	$358.7M	$385.6M
YoY Change	-6.97%	-6.97%	97.0%
LONG-TERM ASSETS
Property, Plant & Equipment	$11.27M	$21.47M	$13.87M
YoY Change	-18.69%	-12.73%	-2.97%
Goodwill	$742.5M		$0.00
YoY Change
Intangibles	$125.6M		$447.0K
YoY Change	27987.25%		14.91%
Long-Term Investments
YoY Change
Other Assets	$2.406M	$2.406M	$1.786M
YoY Change	34.71%	-57.04%	4.69%
Total Long-Term Assets	$905.1M	$905.1M	$36.95M
YoY Change	2349.72%	2352.77%	29.26%
TOTAL ASSETS
Total Short-Term Assets	$358.7M	$358.7M	$385.6M
Total Long-Term Assets	$905.1M	$905.1M	$36.95M
Total Assets	$1.264B	$1.264B	$422.5M
YoY Change	199.1%	199.12%	88.37%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.619M	$4.619M	$1.363M
YoY Change	238.88%	229.93%	10.9%
Accrued Expenses	$19.62M	$37.75M	$5.515M
YoY Change	255.76%	112.07%	-8.36%
Deferred Revenue	$3.280M		$349.0K
YoY Change	839.83%		-69.03%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$36.00K	$36.00K	$13.00K
YoY Change	176.92%		-45.83%
Total Short-Term Liabilities	$327.4M	$327.4M	$81.27M
YoY Change	302.77%	302.64%	3.66%
LONG-TERM LIABILITIES
Long-Term Debt	$184.4M	$184.4M	$174.0M
YoY Change	6.0%	6.0%	1338446.15%
Other Long-Term Liabilities	$4.550M	$61.30M	$679.0K
YoY Change	570.1%	506.92%
Total Long-Term Liabilities	$4.550M	$245.7M	$174.7M
YoY Change	-97.4%	33.49%	115.54%
TOTAL LIABILITIES
Total Short-Term Liabilities	$327.4M	$327.4M	$81.27M
Total Long-Term Liabilities	$4.550M	$245.7M	$174.7M
Total Liabilities	$573.1M	$573.1M	$265.3M
YoY Change	115.98%	116.02%	227.4%
SHAREHOLDERS EQUITY
Retained Earnings	-$522.6M		-$394.1M
YoY Change	32.63%		16.37%
Common Stock	$1.213B		$551.4M
YoY Change	119.94%		14.74%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$690.7M	$690.7M	$157.2M
YoY Change
Total Liabilities & Shareholders Equity	$1.264B	$1.264B	$422.5M
YoY Change	199.1%	199.12%	88.37%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	-$11.84M	-$128.6M	-$6.780M
YoY Change	74.56%	131.97%	-297.67%
Depreciation, Depletion And Amortization	$9.598M	$29.87M	$2.020M
YoY Change	375.15%	281.69%	48.53%
Cash From Operating Activities	-$555.0K	-$38.52M	$5.610M
YoY Change	-109.89%	407.02%	36.83%
INVESTING ACTIVITIES
Capital Expenditures	-$3.414M	$3.108M	-$3.860M
YoY Change	-11.55%	-42.53%	-16.27%
Acquisitions		$494.1M
YoY Change
Other Investing Activities	$0.00	-$494.1M
YoY Change
Cash From Investing Activities	-$3.414M	-$506.7M	-$3.860M
YoY Change	-11.55%	4908.35%	-16.27%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$486.4M
YoY Change		4675.53%
Debt Paid & Issued, Net		$0.00
YoY Change		-100.0%
Cash From Financing Activities	225.0K	$486.0M	3.420M
YoY Change	-93.42%	135.43%	-62.54%
NET CHANGE
Cash From Operating Activities	-555.0K	-$38.52M	5.610M
Cash From Investing Activities	-3.414M	-$506.7M	-3.860M
Cash From Financing Activities	225.0K	$486.0M	3.420M
Net Change In Cash	-3.744M	-$59.79M	5.170M
YoY Change	-172.42%	-131.67%	-40.02%
FREE CASH FLOW
Cash From Operating Activities	-$555.0K	-$38.52M	$5.610M
Capital Expenditures	-$3.414M	$3.108M	-$3.860M
Free Cash Flow	$2.859M	-$41.63M	$9.470M
YoY Change	-69.81%	220.09%	8.73%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001666071
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentNet
CY2020Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentNet
CY2020Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent
CY2021Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesCurrent
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2020Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2020Q4	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	3785000	USD
CY2021	dei	Entity File Number EntityFileNumber	001-38386
CY2021	dei	Entity Registrant Name EntityRegistrantName	CARDLYTICS, INC.
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-3039436
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	675 Ponce de Leon Ave. NE, Ste 6000
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Atlanta
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	GA
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	30308
CY2021	dei	City Area Code CityAreaCode	(888)
CY2021	dei	Local Phone Number LocalPhoneNumber	792-5802
CY2021	dei	Security12b Title Security12bTitle	Common Stock
CY2021	dei	Trading Symbol TradingSymbol	CDLX
CY2021	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	false
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	4100000000	USD
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	33742698	shares
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021	dei	Auditor Firm AuditorFirmId	34
CY2021	dei	Auditor Name AuditorName	DELOITTE & TOUCHE LLP
CY2021	dei	Auditor Location AuditorLocation	Atlanta, Georgia
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	293239000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	233467000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	110000	USD
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	95000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	81249000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	111085000	USD
CY2020Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	5306000	USD
CY2021Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	6097000	USD
CY2020Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5687000	USD
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	7981000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	385591000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	358725000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13865000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11273000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	10764000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	10196000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	447000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	125550000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	0	USD
CY2021Q4	us-gaap	Goodwill Goodwill	742516000	USD
CY2020Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	6299000	USD
CY2021Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	13131000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	3280000	USD
CY2021Q4	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	0	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	1786000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2406000	USD
CY2020Q4	us-gaap	Assets Assets	422537000	USD
CY2021Q4	us-gaap	Assets Assets	1263797000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1363000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	4619000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	7582000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	12136000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5515000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	19620000	USD
CY2020Q4	cdlx	Financial Institution Share Liability Current FinancialInstitutionShareLiabilityCurrent	37457000	USD
CY2021Q4	cdlx	Financial Institution Share Liability Current FinancialInstitutionShareLiabilityCurrent	46595000	USD
CY2020Q4	cdlx	Customer Incentive Liability CustomerIncentiveLiability	24290000	USD
CY2021Q4	cdlx	Customer Incentive Liability CustomerIncentiveLiability	52602000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	349000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4718000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6028000	USD
CY2020Q4	cdlx	Contingent Consideration Liability Current ContingentConsiderationLiabilityCurrent	0	USD
CY2021Q4	cdlx	Contingent Consideration Liability Current ContingentConsiderationLiabilityCurrent	182470000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	81274000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	327350000	USD
CY2020Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	174011000	USD
CY2021Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	184398000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	0	USD
CY2021Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	173000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	9381000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6801000	USD
CY2020Q4	cdlx	Contingent Consideration Liability Long Term ContingentConsiderationLiabilityLongTerm	0	USD
CY2021Q4	cdlx	Contingent Consideration Liability Long Term ContingentConsiderationLiabilityLongTerm	49825000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	679000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	4550000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	265345000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	573097000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	8000	USD
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	9000	USD
CY2020Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	551429000	USD
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1212823000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-192000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	486000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-394053000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-522618000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	157192000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	690700000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	422537000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1263797000	USD
CY2019	us-gaap	Revenues Revenues	210430000	USD
CY2020	us-gaap	Revenues Revenues	186892000	USD
CY2021	us-gaap	Revenues Revenues	267116000	USD
CY2019	cdlx	Financial Institution Share And Other Third Party Costs FinancialInstitutionShareAndOtherThirdPartyCosts	118080000	USD
CY2020	cdlx	Financial Institution Share And Other Third Party Costs FinancialInstitutionShareAndOtherThirdPartyCosts	109308000	USD
CY2021	cdlx	Financial Institution Share And Other Third Party Costs FinancialInstitutionShareAndOtherThirdPartyCosts	141273000	USD
CY2019	cdlx	Delivery Costs DeliveryCosts	12893000	USD
CY2020	cdlx	Delivery Costs DeliveryCosts	14310000	USD
CY2021	cdlx	Delivery Costs DeliveryCosts	22503000	USD
CY2019	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	43828000	USD
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	45307000	USD
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	65996000	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11699000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	17532000	USD
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	38104000	USD
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	36720000	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	46532000	USD
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	66222000	USD
CY2019	us-gaap	Acquisition Costs AcquisitionCosts	0	USD
CY2019	cdlx	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	0	USD
CY2020	cdlx	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	0	USD
CY2020	us-gaap	Acquisition Costs AcquisitionCosts	0	USD
CY2021	us-gaap	Acquisition Costs AcquisitionCosts	24372000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1549000	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-1267000	USD
CY2021	cdlx	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	1374000	USD
CY2019	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4535000	USD
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	7826000	USD
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	29871000	USD
CY2019	us-gaap	Costs And Expenses CostsAndExpenses	227755000	USD
CY2020	us-gaap	Costs And Expenses CostsAndExpenses	240815000	USD
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	389715000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-17325000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-53923000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-122599000	USD
CY2019	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-548000	USD
CY2020	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-3048000	USD
CY2021	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-12563000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	729000	USD
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	181000	USD
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1499000	USD
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-13830000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-17144000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-55422000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-136429000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7864000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-17144000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-55422000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-128565000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-17144000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-55422000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-128565000	USD
CY2019	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.72
CY2020	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.04
CY2021	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-3.99
CY2019	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	23746000	shares
CY2020	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	27213000	shares
CY2021	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	32202000	shares
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-17144000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-55422000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-128565000	USD
CY2019	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-680000	USD
CY2020	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-1504000	USD
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	678000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-17824000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-56926000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-127887000	USD
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	51975000	USD
CY2019	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	12052000	USD
CY2019	cdlx	Stock Issued During Period Shares Warrants Exercised In Period StockIssuedDuringPeriodSharesWarrantsExercisedInPeriod	17659000	shares
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	15888000	USD
CY2019	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	61309000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	2208000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-680000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-17144000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	143267000	USD
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	10176000	USD
CY2020	cdlx	Stock Issued During Period Shares Warrants Exercised In Period StockIssuedDuringPeriodSharesWarrantsExercisedInPeriod	0	shares
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	32872000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	2837000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Employee Stock Purchase Program Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition	2837000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	51416000	USD
CY2020	cdlx	Adjustments To Additional Paid In Capital Purchase Of Capped Calls AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCalls	-26450000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-1504000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-55422000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	157192000	USD
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2155000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	50224000	USD
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	484049000	USD
CY2021	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	117349000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Other Longterm Incentive Plans Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationOtherLongtermIncentivePlansRequisiteServicePeriodRecognition	841000	USD
CY2021	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	3184000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	678000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-128565000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	690700000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-17144000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-55422000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-128565000	USD
CY2019	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1201000	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1196000	USD
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1702000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4535000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7826000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	29871000	USD
CY2019	cdlx	Capitalized Contract Cost Amortization Interest Expense CapitalizedContractCostAmortizationInterestExpense	95000	USD
CY2020	cdlx	Capitalized Contract Cost Amortization Interest Expense CapitalizedContractCostAmortizationInterestExpense	312000	USD
CY2021	cdlx	Capitalized Contract Cost Amortization Interest Expense CapitalizedContractCostAmortizationInterestExpense	968000	USD
CY2019	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	0	USD
CY2020	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	3766000	USD
CY2021	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	5783000	USD
CY2019	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	0	USD
CY2020	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2486000	USD
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	9513000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	15851000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	32396000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	50264000	USD
CY2019	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
CY2020	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	1374000	USD
CY2019	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-570000	USD
CY2020	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1003000	USD
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	1343000	USD
CY2019	cdlx	Contractwith Customer Asset Deferred Implementation Costs Amortization ContractwithCustomerAssetDeferredImplementationCostsAmortization	2869000	USD
CY2020	cdlx	Contractwith Customer Asset Deferred Implementation Costs Amortization ContractwithCustomerAssetDeferredImplementationCostsAmortization	4598000	USD
CY2021	cdlx	Contractwith Customer Asset Deferred Implementation Costs Amortization ContractwithCustomerAssetDeferredImplementationCostsAmortization	3785000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7864000	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	26018000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2396000	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	27936000	USD
CY2019	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-2224000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	65000	USD
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	1466000	USD
CY2019	cdlx	Contractwith Customer Asset Deferred Financial Institution Implementation Costs Recoveries Through Financial Institution Share Net ContractwithCustomerAssetDeferredFinancialInstitutionImplementationCostsRecoveriesThroughFinancialInstitutionShareNet	4625000	USD
CY2020	cdlx	Contractwith Customer Asset Deferred Financial Institution Implementation Costs Recoveries Through Financial Institution Share Net ContractwithCustomerAssetDeferredFinancialInstitutionImplementationCostsRecoveriesThroughFinancialInstitutionShareNet	0	USD
CY2021	cdlx	Contractwith Customer Asset Deferred Financial Institution Implementation Costs Recoveries Through Financial Institution Share Net ContractwithCustomerAssetDeferredFinancialInstitutionImplementationCostsRecoveriesThroughFinancialInstitutionShareNet	0	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-601000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	16000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1260000	USD
CY2019	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	6152000	USD
CY2020	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-1238000	USD
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-905000	USD
CY2019	cdlx	Increase Decrease In Financial Institution Share Liability IncreaseDecreaseInFinancialInstitutionShareLiability	14301000	USD
CY2020	cdlx	Increase Decrease In Financial Institution Share Liability IncreaseDecreaseInFinancialInstitutionShareLiability	-4499000	USD
CY2021	cdlx	Increase Decrease In Financial Institution Share Liability IncreaseDecreaseInFinancialInstitutionShareLiability	9139000	USD
CY2019	cdlx	Increase Decrease In Consumer Incentive Liability IncreaseDecreaseInConsumerIncentiveLiability	8385000	USD
CY2020	cdlx	Increase Decrease In Consumer Incentive Liability IncreaseDecreaseInConsumerIncentiveLiability	4429000	USD
CY2021	cdlx	Increase Decrease In Consumer Incentive Liability IncreaseDecreaseInConsumerIncentiveLiability	13211000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	11457000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7598000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-38523000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	8277000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5408000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	3108000	USD
CY2019	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	31000	USD
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	76000	USD
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	133000	USD
CY2019	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	2712000	USD
CY2020	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	4633000	USD
CY2021	us-gaap	Payments To Develop Software PaymentsToDevelopSoftware	9323000	USD
CY2019	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	494131000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11020000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-10117000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-506695000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-506695000	USD
CY2019	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	46698000	USD
CY2020	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	23000	USD
CY2021	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	USD
CY2019	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
CY2020	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	223100000	USD
CY2021	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
CY2019	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	0	USD
CY2020	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	26450000	USD
CY2021	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	0	USD
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	91216000	USD
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	10185000	USD
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	486388000	USD
CY2019	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	196000	USD
CY2020	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	0	USD
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	190000	USD
CY2019	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	143000	USD
CY2020	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	382000	USD
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	200000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	44179000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	206430000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	485998000	USD
CY2019	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	101000	USD
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	47000	USD
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-567000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	44717000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	188762000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-59787000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	59870000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	104587000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	293349000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	104587000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	293349000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	233562000	USD
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	104458000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	71000	USD
CY2021Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	2200000	USD
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	29700000	USD
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	10200000	USD
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2200000	USD
CY2021Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	230000000	USD
CY2021Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0100
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consolidated financial statements. Significant items subject to such estimates and assumptions include revenue </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recognition, internal-use software development costs, stock-based compensation, allowance for doubtful accounts, </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">valuation of acquired intangible assets of Dosh and Bridg, valuation of contingent consideration for Bridg, income tax including </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">valuation allowance and contingencies. We base our estimates on historical experience and on assumptions that we believe are </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reasonable. Changes in facts or circumstances may cause us to change our assumptions and estimates in future periods and it is possible that actual results could differ from our current or revised future estimates</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restructuring</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2020, we began a strategic shift within our organization to increase productivity and optimize performance. This plan resulted in severance and medical benefits totaling $1.3 million during the year ended December 31, 2020. We recognize these costs when the extent of our actions is determined and the costs can be estimated. These charges are reflected on our consolidated statement of operations for the year ended December 31, 2020, as follows: $1.1 million in sales and marketing expense, $0.1 million in general and administrative expense and $0.1 million in research and development expense. Severance and medical benefits of $0.9 million had been paid to former employees through December 31, 2020.</span></div>As a part of our integration efforts with our acquired companies, we have continued to evaluate the optimal structure of the combined organization. As a result, during the year ended December 31, 2021 we have recognized $1.2 million in severance and medical benefits related to our acquisitions. These charges are reflected on our consolidated statement of operations within acquisition and integration costs. Additionally, during the year ended December 31, 2021, we recognized $0.8 million of severance and medical benefits charges related to internal restructuring. These charges are reflected on our consolidated statement of operations as follows: $0.1 million in delivery costs, $0.4 million in sales and marketing expense, and $0.3 million in research and development expense. We recognize these costs when the extent of our actions is determined and the costs can be estimated. As of December 31, 2021, $0.6 million of severance and medical benefits related to integration efforts and 2021 restructuring owed to former employees remains unpaid.
CY2021	cdlx	Number Of Patents Approved NumberOfPatentsApproved	7	patent
CY2015	cdlx	Number Of Patents Approved NumberOfPatentsApproved	3	patent
CY2020	cdlx	Number Of Patents Approved NumberOfPatentsApproved	1	patent
CY2019Q4	cdlx	Finite Lived Intangible Assets Not Yet Capitalized FiniteLivedIntangibleAssetsNotYetCapitalized	300000	USD
CY2020Q4	cdlx	Finite Lived Intangible Assets Not Yet Capitalized FiniteLivedIntangibleAssetsNotYetCapitalized	400000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	518000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	647000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	85000	USD
CY2018Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	169000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	255000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	587000	USD
CY2019	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1201000	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1196000	USD
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1702000	USD
CY2019	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	1115000	USD
CY2020	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	864000	USD
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	962000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	255000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	587000	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1327000	USD
CY2019Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	600000	USD
CY2020Q4	us-gaap	Unbilled Receivables Current UnbilledReceivablesCurrent	500000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	293239000	USD
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	233467000	USD
CY2019Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	129000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	110000	USD
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	95000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	104587000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	293349000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	233562000	USD
CY2019Q4	cdlx	Property And Equipment Incurred But Not Yet Paid PropertyAndEquipmentIncurredButNotYetPaid	456000	USD
CY2020Q4	cdlx	Property And Equipment Incurred But Not Yet Paid PropertyAndEquipmentIncurredButNotYetPaid	242000	USD
CY2021Q4	cdlx	Property And Equipment Incurred But Not Yet Paid PropertyAndEquipmentIncurredButNotYetPaid	267000	USD
CY2019Q4	cdlx	Capitalized Software Development Costs Incurredbut Notyet Paid CapitalizedSoftwareDevelopmentCostsIncurredbutNotyetPaid	10000	USD
CY2020Q4	cdlx	Capitalized Software Development Costs Incurredbut Notyet Paid CapitalizedSoftwareDevelopmentCostsIncurredbutNotyetPaid	68000	USD
CY2021Q4	cdlx	Capitalized Software Development Costs Incurredbut Notyet Paid CapitalizedSoftwareDevelopmentCostsIncurredbutNotyetPaid	253000	USD
CY2019Q3	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	1904154	shares
CY2019Q3	cdlx	Proceeds From Issuance Secondary Public Offering Net ProceedsFromIssuanceSecondaryPublicOfferingNet	61300000	USD
CY2019Q3	cdlx	Saleof Stock Issuance Costs SaleofStockIssuanceCosts	200000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	447000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	562000	USD
CY2020Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	9230000	USD
CY2021Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	19495000	USD
CY2020Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	2931000	USD
CY2021Q4	us-gaap	Capitalized Computer Software Accumulated Amortization CapitalizedComputerSoftwareAccumulatedAmortization	6364000	USD
CY2020Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	6299000	USD
CY2021Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	13131000	USD
CY2021Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	230000000	USD
CY2021Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0100
CY2020Q3	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	222700000	USD
CY2021Q4	cdlx	Debt Issuance Costs Amortization Year Two DebtIssuanceCostsAmortizationYearTwo	1145000	USD
CY2021Q4	cdlx	Debt Issuance Costs Amortization Year Three DebtIssuanceCostsAmortizationYearThree	1151000	USD
CY2021Q4	cdlx	Debt Issuance Costs Amortization Year Four DebtIssuanceCostsAmortizationYearFour	1312000	USD
CY2021Q4	cdlx	Debt Issuance Costs Amortization Year Five DebtIssuanceCostsAmortizationYearFive	1036000	USD
CY2021Q4	us-gaap	Unamortized Debt Issuance Expense UnamortizedDebtIssuanceExpense	4644000	USD
CY2018Q4	us-gaap	Deferred Costs DeferredCosts	0	USD
CY2019Q4	us-gaap	Deferred Costs DeferredCosts	0	USD
CY2020Q4	us-gaap	Deferred Costs DeferredCosts	0	USD
CY2019	cdlx	Deferred Offering Costs Incurred During Period DeferredOfferingCostsIncurredDuringPeriod	196000	USD
CY2020	cdlx	Deferred Offering Costs Incurred During Period DeferredOfferingCostsIncurredDuringPeriod	0	USD
CY2021	cdlx	Deferred Offering Costs Incurred During Period DeferredOfferingCostsIncurredDuringPeriod	190000	USD
CY2019	cdlx	Saleof Stock Issuance Costs SaleofStockIssuanceCosts	196000	USD
CY2020	cdlx	Saleof Stock Issuance Costs SaleofStockIssuanceCosts	0	USD
CY2021	cdlx	Saleof Stock Issuance Costs SaleofStockIssuanceCosts	190000	USD
CY2019Q4	us-gaap	Deferred Costs DeferredCosts	0	USD
CY2020Q4	us-gaap	Deferred Costs DeferredCosts	0	USD
CY2021Q4	us-gaap	Deferred Costs DeferredCosts	0	USD
CY2019	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	1400000	USD
CY2020	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	1000000	USD
CY2021	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	3700000	USD
CY2021Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities	5562000	USD
CY2021Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities	2302000	USD
CY2020	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	223259000	USD
CY2021Q4	us-gaap	Business Acquisitions Pro Forma Revenue BusinessAcquisitionsProFormaRevenue	274486000	USD
CY2020	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-92883000	USD
CY2021Q4	us-gaap	Business Acquisitions Pro Forma Net Income Loss BusinessAcquisitionsProFormaNetIncomeLoss	-138422000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	0	USD
CY2021	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	742516000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	742516000	USD
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	19700000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	26186000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	26120000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	25400000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	25252000	USD
CY2021Q4	cdlx	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	17558000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	4472000	USD
CY2019	cdlx	Consumer Incentives Expense ConsumerIncentivesExpense	105600000	USD
CY2020	cdlx	Consumer Incentives Expense ConsumerIncentivesExpense	76500000	USD
CY2021	cdlx	Consumer Incentives Expense ConsumerIncentivesExpense	127000000.0	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	210430000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	186892000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	258754000	USD
CY2021Q4	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	78000	USD
CY2021Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	17900000	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	5100000	USD
CY2021	cdlx	Increase In Operating Lease Liability IncreaseInOperatingLeaseLiability	5500000	USD
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	4000000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	7300000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	10764000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	10196000	USD
CY2020Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	9000	USD
CY2021Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	86000	USD
CY2020Q4	cdlx	Total Lease Assets TotalLeaseAssets	10773000	USD
CY2021Q4	cdlx	Total Lease Assets TotalLeaseAssets	10282000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4718000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	6028000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	9381000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	6801000	USD
CY2020Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	13000	USD
CY2021Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	36000	USD
CY2020Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	0	USD
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	50000	USD
CY2020Q4	cdlx	Total Lease Liabilities TotalLeaseLiabilities	14112000	USD
CY2021Q4	cdlx	Total Lease Liabilities TotalLeaseLiabilities	12915000	USD
CY2020	us-gaap	Operating Lease Expense OperatingLeaseExpense	4078000	USD
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	5632000	USD
CY2020	us-gaap	Variable Lease Cost VariableLeaseCost	847000	USD
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	936000	USD
CY2020	us-gaap	Short Term Lease Cost ShortTermLeaseCost	232000	USD
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	119000	USD
CY2020	us-gaap	Lease Cost LeaseCost	5157000	USD
CY2021	us-gaap	Lease Cost LeaseCost	6687000	USD
CY2020Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.034
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.034
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y3M
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y4M9D
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	6334000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	4472000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1920000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	611000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	13337000	USD
CY2020Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	508000	USD
CY2020Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	12829000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	35112000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	37798000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	21247000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	26525000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13865000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11273000	USD
CY2019	us-gaap	Depreciation Nonproduction DepreciationNonproduction	4000000	USD
CY2020	us-gaap	Depreciation Nonproduction DepreciationNonproduction	5600000	USD
CY2021	us-gaap	Depreciation Nonproduction DepreciationNonproduction	6700000	USD
CY2020Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	174011000	USD
CY2021Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	184398000	USD
CY2021Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	230000000	USD
CY2021Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0100
CY2021Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0100
CY2020Q3	us-gaap	Debt Instrument Convertible Threshold Consecutive Trading Days1 DebtInstrumentConvertibleThresholdConsecutiveTradingDays1	30000	numberOfDays
CY2020Q3	us-gaap	Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger	1.30
CY2020Q3	us-gaap	Debt Instrument Convertible Conversion Ratio1 DebtInstrumentConvertibleConversionRatio1	11.7457
CY2020Q3	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	85140
CY2020Q3	us-gaap	Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger	1.30
CY2020Q3	us-gaap	Debt Instrument Convertible Threshold Consecutive Trading Days1 DebtInstrumentConvertibleThresholdConsecutiveTradingDays1	30000	numberOfDays
CY2020Q3	us-gaap	Debt Instrument Redemption Price Percentage DebtInstrumentRedemptionPricePercentage	1
CY2020Q3	us-gaap	Debt Instrument Redemption Price Percentage DebtInstrumentRedemptionPricePercentage	1
CY2020Q3	us-gaap	Debt Instrument Convertible Threshold Consecutive Trading Days1 DebtInstrumentConvertibleThresholdConsecutiveTradingDays1	30000	numberOfDays
CY2020Q3	us-gaap	Debt Instrument Convertible Threshold Consecutive Trading Days1 DebtInstrumentConvertibleThresholdConsecutiveTradingDays1	30000	numberOfDays
CY2020Q3	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	222700000	USD
CY2020Q3	us-gaap	Debt Instrument Call Feature DebtInstrumentCallFeature	26.5 million
CY2020Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	230000000	USD
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	230000000	USD
CY2020Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	50610000	USD
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	41098000	USD
CY2020Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	5379000	USD
CY2021Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	4504000	USD
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	174011000	USD
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	184398000	USD
CY2020Q4	us-gaap	Debt Instrument Convertible Carrying Amount Of The Equity Component DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent	53096000	USD
CY2021Q4	us-gaap	Debt Instrument Convertible Carrying Amount Of The Equity Component DebtInstrumentConvertibleCarryingAmountOfTheEquityComponent	53096000	USD
CY2020Q4	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	1680000	USD
CY2021Q4	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	1680000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt Subsequent Adjustments AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments	51416000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt Subsequent Adjustments AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebtSubsequentAdjustments	51416000	USD
CY2020	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	626000	USD
CY2021	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	2300000	USD
CY2020	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2486000	USD
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	9513000	USD
CY2020	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	217000	USD
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	874000	USD
CY2020	us-gaap	Interest Expense Debt InterestExpenseDebt	3329000	USD
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	12687000	USD
CY2020Q4	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0532
CY2021	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	500000	USD
CY2021Q4	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.0552
CY2020Q3	us-gaap	Debt Instrument Call Feature DebtInstrumentCallFeature	26.5 million
CY2021Q4	cdlx	Line Of Credit Facility Maximum Borrowing Capacity Percentage Of Eligible Accounts Receivable LineOfCreditFacilityMaximumBorrowingCapacityPercentageOfEligibleAccountsReceivable	0.85
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	2033227	shares
CY2021Q4	cdlx	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized Annual Percentage Increase ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorizedAnnualPercentageIncrease	0.05
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	1676682	shares
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	15851000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	32396000	USD
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	50264000	USD
CY2021	us-gaap	Capital Lease Obligations Incurred CapitalLeaseObligationsIncurred	500000	USD
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P10Y
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1774000	shares
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	20.55
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	39000	shares
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	20.64
CY2019	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	716000	shares
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	16.84
CY2019Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	21399000	USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	31000	shares
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	23.95
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	66000	shares
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	22.37
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1000000	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	22.99
CY2020	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	467000	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	21.78
CY2020Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	29523000	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	19000	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	27.83
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	1000	shares
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	21.89
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	513000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	23.91
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	106000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	19.11
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	9710000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	1000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	22.16
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	406000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	25.17
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	16608000	USD
CY2021Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	406000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	25.17
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	16608000	USD
CY2019Q2	cdlx	Sharebased Compensation Arrangementby Sharebased Payment Award Monthly Average Closing Price Common Stock Threshold SharebasedCompensationArrangementbySharebasedPaymentAwardMonthlyAverageClosingPriceCommonStockThreshold	66.09
CY2019Q2	cdlx	Sharebased Compensation Arrangementby Sharebased Payment Award Monthly Average Closing Price Common Stock Threshold SharebasedCompensationArrangementbySharebasedPaymentAwardMonthlyAverageClosingPriceCommonStockThreshold	66.09
CY2021	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	711255	shares
CY2020Q1	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	335336000	shares
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-13464000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-42613000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-122087000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-3680000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-12809000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-14342000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-17144000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-55422000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-136429000	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	0	USD
CY2019	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	USD
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	USD
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	0	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	0	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	1326000	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	23062000	USD
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	31106000	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	622000	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	3744000	USD
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	4942000	USD
CY2019	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	222000	USD
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	1713000	USD
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	2184000	USD
CY2019	us-gaap	Tax Adjustments Settlements And Unusual Provisions TaxAdjustmentsSettlementsAndUnusualProvisions	598000	USD
CY2020	us-gaap	Tax Adjustments Settlements And Unusual Provisions TaxAdjustmentsSettlementsAndUnusualProvisions	-117000	USD
CY2021	us-gaap	Tax Adjustments Settlements And Unusual Provisions TaxAdjustmentsSettlementsAndUnusualProvisions	-596000	USD
CY2019	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	2768000	USD
CY2020	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	28402000	USD
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	29772000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	7864000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	7864000	USD
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2019	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0
CY2020	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0208
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.0034
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	0.0035
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.0014
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.0020
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.0062
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.0019
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.0518
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.0736
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.0468
CY2019	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.1618
CY2020	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.2857
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.2176
CY2019	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0022
CY2020	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0048
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.0568
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	92387000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	145273000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	94000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Allowance For Doubtful Accounts DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAllowanceForDoubtfulAccounts	212000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	13601000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	42053000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3769000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	7889000	USD
CY2020Q4	cdlx	Deferred Tax Assets Change In Fair Value Of Convertible Promissory Notes DeferredTaxAssetsChangeInFairValueOfConvertiblePromissoryNotes	1462000	USD
CY2021Q4	cdlx	Deferred Tax Assets Change In Fair Value Of Convertible Promissory Notes DeferredTaxAssetsChangeInFairValueOfConvertiblePromissoryNotes	7898000	USD
CY2020Q4	cdlx	Deferred Tax Assets Tax Deferred Expense Interest Expense Limitation DeferredTaxAssetsTaxDeferredExpenseInterestExpenseLimitation	89000	USD
CY2021Q4	cdlx	Deferred Tax Assets Tax Deferred Expense Interest Expense Limitation DeferredTaxAssetsTaxDeferredExpenseInterestExpenseLimitation	77000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	1771000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	4249000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	20000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	322000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	85991000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	123867000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2021Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0	USD
CY2018Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	67463000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	70231000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	85991000	USD
CY2019	cdlx	Valuation Allowance Increase Decrease In Allowance For Operating Loss Carryforwards ValuationAllowanceIncreaseDecreaseInAllowanceForOperatingLossCarryforwards	-3598000	USD
CY2020	cdlx	Valuation Allowance Increase Decrease In Allowance For Operating Loss Carryforwards ValuationAllowanceIncreaseDecreaseInAllowanceForOperatingLossCarryforwards	-26277000	USD
CY2021	cdlx	Valuation Allowance Increase Decrease In Allowance For Operating Loss Carryforwards ValuationAllowanceIncreaseDecreaseInAllowanceForOperatingLossCarryforwards	-51856000	USD
CY2019	cdlx	Valuation Allowance Increase Decrease In Tax Rate Change ValuationAllowanceIncreaseDecreaseInTaxRateChange	-32000	USD
CY2020	cdlx	Valuation Allowance Increase Decrease In Tax Rate Change ValuationAllowanceIncreaseDecreaseInTaxRateChange	-82000	USD
CY2021	cdlx	Valuation Allowance Increase Decrease In Tax Rate Change ValuationAllowanceIncreaseDecreaseInTaxRateChange	419000	USD
CY2019	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	0	USD
CY2020	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	12642000	USD
CY2021	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	0	USD
CY2019	cdlx	Valuation Allowance Other Increase Decrease ValuationAllowanceOtherIncreaseDecrease	862000	USD
CY2020	cdlx	Valuation Allowance Other Increase Decrease ValuationAllowanceOtherIncreaseDecrease	-2043000	USD
CY2021	cdlx	Valuation Allowance Other Increase Decrease ValuationAllowanceOtherIncreaseDecrease	13561000	USD
CY2019Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	70231000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	85991000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	123867000	USD
CY2019Q4	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	1300000	USD
CY2020Q4	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	1400000	USD
CY2021Q4	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	1300000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	783000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	185000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	302000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	598000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	117000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	826000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	185000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	302000	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1128000	USD
CY2018Q4	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	15877000	USD
CY2019Q4	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	8383000	USD
CY2020Q4	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	3785000	USD
CY2019	cdlx	Contractwith Customer Asset Deferred Financial Institution Implementation Costs Recoveries Through Financial Institution Share Net ContractwithCustomerAssetDeferredFinancialInstitutionImplementationCostsRecoveriesThroughFinancialInstitutionShareNet	4625000	USD
CY2020	cdlx	Contractwith Customer Asset Deferred Financial Institution Implementation Costs Recoveries Through Financial Institution Share Net ContractwithCustomerAssetDeferredFinancialInstitutionImplementationCostsRecoveriesThroughFinancialInstitutionShareNet	0	USD
CY2021	cdlx	Contractwith Customer Asset Deferred Financial Institution Implementation Costs Recoveries Through Financial Institution Share Net ContractwithCustomerAssetDeferredFinancialInstitutionImplementationCostsRecoveriesThroughFinancialInstitutionShareNet	0	USD
CY2019	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	2869000	USD
CY2020	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	3915000	USD
CY2021	us-gaap	Capitalized Contract Cost Amortization CapitalizedContractCostAmortization	2826000	USD
CY2019	us-gaap	Impairment Of Ongoing Project ImpairmentOfOngoingProject	0	USD
CY2020	us-gaap	Impairment Of Ongoing Project ImpairmentOfOngoingProject	683000	USD
CY2021	us-gaap	Impairment Of Ongoing Project ImpairmentOfOngoingProject	959000	USD
CY2019Q4	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	8383000	USD
CY2020Q4	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	3785000	USD
CY2021Q4	us-gaap	Capitalized Contract Cost Net Noncurrent CapitalizedContractCostNetNoncurrent	0	USD
CY2021Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	230000000	USD
CY2021Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.0100
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2019	cdlx	Adjusted Contribution AdjustedContribution	95219000	USD
CY2020	cdlx	Adjusted Contribution AdjustedContribution	82182000	USD
CY2021	cdlx	Adjusted Contribution AdjustedContribution	129628000	USD
CY2019	cdlx	Financial Institution Share And Other Third Party Costs Excluding Noncash Equity Expenseand Deferred Implementation Costs FinancialInstitutionShareAndOtherThirdPartyCostsExcludingNoncashEquityExpenseandDeferredImplementationCosts	115211000	USD
CY2020	cdlx	Financial Institution Share And Other Third Party Costs Excluding Noncash Equity Expenseand Deferred Implementation Costs FinancialInstitutionShareAndOtherThirdPartyCostsExcludingNoncashEquityExpenseandDeferredImplementationCosts	104710000	USD
CY2021	cdlx	Financial Institution Share And Other Third Party Costs Excluding Noncash Equity Expenseand Deferred Implementation Costs FinancialInstitutionShareAndOtherThirdPartyCostsExcludingNoncashEquityExpenseandDeferredImplementationCosts	137488000	USD
CY2019	us-gaap	Revenues Revenues	210430000	USD
CY2020	us-gaap	Revenues Revenues	186892000	USD
CY2021	us-gaap	Revenues Revenues	267116000	USD
CY2019	cdlx	Adjusted Contribution AdjustedContribution	95219000	USD
CY2020	cdlx	Adjusted Contribution AdjustedContribution	82182000	USD
CY2021	cdlx	Adjusted Contribution AdjustedContribution	129628000	USD
CY2019	cdlx	Contractwith Customer Asset Deferred Implementation Costs Amortization ContractwithCustomerAssetDeferredImplementationCostsAmortization	2869000	USD
CY2020	cdlx	Contractwith Customer Asset Deferred Implementation Costs Amortization ContractwithCustomerAssetDeferredImplementationCostsAmortization	4598000	USD
CY2021	cdlx	Contractwith Customer Asset Deferred Implementation Costs Amortization ContractwithCustomerAssetDeferredImplementationCostsAmortization	3785000	USD
CY2019	cdlx	Delivery Costs DeliveryCosts	12893000	USD
CY2020	cdlx	Delivery Costs DeliveryCosts	14310000	USD
CY2021	cdlx	Delivery Costs DeliveryCosts	22503000	USD
CY2019	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	43828000	USD
CY2020	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	45307000	USD
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	65996000	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	11699000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	17532000	USD
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	38104000	USD
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	36720000	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	46532000	USD
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	66222000	USD
CY2019	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4535000	USD
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	7826000	USD
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	29871000	USD
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	181000	USD
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1499000	USD
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-13830000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-17144000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-55422000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-136429000	USD
CY2019	us-gaap	Revenues Revenues	210430000	USD
CY2020	us-gaap	Revenues Revenues	186892000	USD
CY2021	us-gaap	Revenues Revenues	267116000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13865000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	11273000	USD

Files In Submission

Name	View Source	Status
0001666071-22-000022-index-headers.html	Edgar Link	pending
0001666071-22-000022-index.html	Edgar Link	pending
0001666071-22-000022.txt	Edgar Link	pending
0001666071-22-000022-xbrl.zip	Edgar Link	pending
cdlx-20211231.htm	Edgar Link	pending
cdlx-20211231.xsd	Edgar Link	pending
cdlx-20211231_cal.xml	Edgar Link	unprocessable
cdlx-20211231_def.xml	Edgar Link	unprocessable
cdlx-20211231_g1.jpg	Edgar Link	pending
cdlx-20211231_g2.jpg	Edgar Link	pending
cdlx-20211231_htm.xml	Edgar Link	completed
cdlx-20211231_lab.xml	Edgar Link	unprocessable
cdlx-20211231_pre.xml	Edgar Link	unprocessable
cdlx_form10-kx2021xex1013.htm	Edgar Link	pending
cdlx_form10-kx2021xex1029.htm	Edgar Link	pending
cdlx_form10-kx2021xex1030.htm	Edgar Link	pending
cdlx_form10-kx2021xex1031.htm	Edgar Link	pending
cdlx_form10-kx2021xex1032.htm	Edgar Link	pending
cdlx_form10-kx2021xex211.htm	Edgar Link	pending
cdlx_form10-kx2021xex231.htm	Edgar Link	pending
cdlx_form10-kx2021xex311.htm	Edgar Link	pending
cdlx_form10-kx2021xex312.htm	Edgar Link	pending
cdlx_form10-kx2021xex321.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
image.jpg	Edgar Link	pending
imagea.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CDLX
Cardlytics, Inc. Stock $cdlx

2021 Q4 Form 10-K Financial Statement

#000166607122000022 Filed on March 01, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CDLX Cardlytics, Inc. Stock $cdlx

2021 Q4 Form 10-K Financial Statement

#000166607122000022 Filed on March 01, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CDLX
Cardlytics, Inc. Stock $cdlx